Hubei Cancer Hospital ( Site 2429)

Wuhan, Hubei 430079

0 studies enrolling now · 1 studies all time

What they study most

Advanced/Metastatic Gastroesophageal Adenocarcinoma

Studies at this site

• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015) — Completed